Abstract
We present the case of an asymptomatic HIV carrier, who presented with acute myeloblastic leukemia in third relapse and successfully underwent autologous stem cell transplantation as a rescue treatment. This observation supports the conclusion that tolerance of autologous bone marrow or stem cell transplant in patients with HIV may correlate with a low viral burden and relatively good immune function.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schneider, E., Lambermont, M., Van Vooren, JP. et al. Autologous stem cell infusion for acute myeloblastic leukemia in an HIV-1 carrier. Bone Marrow Transplant 20, 611–612 (1997). https://doi.org/10.1038/sj.bmt.1700930
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700930
Keywords
This article is cited by
-
Acute myelogenous leukemia in a child with HIV infection
European Journal of Pediatrics (2010)
-
Successful unrelated bone marrow transplantation for a human immunodeficiency virus type-1-seropositive acute myelogenous leukemia patient following HAART
International Journal of Hematology (2010)
-
High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier
Bone Marrow Transplantation (2002)